Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Express Scripts Earnings Surged 74%; Forecast Clears Lowered Hurdle

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/18/2013 | 11:18pm CET
   By Jon Kamp 
 

Pharmacy-benefit manager Express Scripts Holding Co. (>> Express Scripts Holding Co) reported a 74% surge in fourth-quarter earnings, helped by a major acquisition, while forecasting 2013 earnings mostly ahead of a Wall Street target the company helped drag lower three months ago.

The St. Louis-based company--which manages drug-benefit programs for health plans and corporate customers--rattled analysts in November when it said their forecasts for 2013 looked too high. Express Scripts didn't release its own guidance at the time, but said a still-weak economy was weighing on the number of prescriptions it handles.

Monday's release finally included company guidance for adjusted earnings of $4.20 to $4.30 per share this year. The target is largely above the $4.20 forecast among analysts surveyed by Thomson Reuters, although Express Scripts' November warning caused analysts to trim the consensus forecast by about 30 cents since then.

This will mark the first full year of combined operations for Express Scripts and Medco Health Solutions, which created the largest pharmacy-benefit manager, or PBM, following April's $29.1 billion Medco acquisition.

"2012 was a monumental year for Express Scripts as we closed the acquisition of Medco and made significant progress integrating the two companies," George Paz, Express Scripts' chief executive, said in a press release.

The company plans to hold a conference call Tuesday morning. Its shares are up about 2.9% so far this year, through Friday's close, trailing a 6.6% gain in the Standard & Poor's 500 index.

The company reported fourth-quarter earnings of $504.1 million, or 61 cents a share, up from $290.4 million, or 59 cents a share, a year earlier. Excluding deal-related costs and other items, per-share earnings rose to $1.05 from 82 cents.

Revenue more than doubled to $27.41 billion from the year-earlier period, which was before the Medco deal.

Analysts surveyed by Thomson Reuters had forecast earnings of $1.04 a share on sales of $27.24 billion. Analysts are forecasting lower sales in coming quarters as health insurer UnitedHealth Group Inc. (>> UnitedHealth Group Inc.) brings in-house the PBM business it had outsourced to Medco.

Express Scripts saw adjusted claims--a measure that takes into account monthly prescriptions filled in retail pharmacies and 90-day fills through the company's mail-order business--rise 111% in the recent quarter to 410.8 million.

The company's full-year adjusted claims tally about matched its target by nearing 1.4 billion. The company expects 5% to 7% growth in adjusted claims this year.

Its adjusted earnings forecast represents 12% to 15% growth.

Write to Jon Kamp at [email protected]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Express Scripts Holding Co, UnitedHealth Group Inc.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EXPRESS SCRIPTS HOLDING CO
11/16 CVS HEALTH : Surescripts Transforms Prescription Decision Process Between Physic..
11/15 EXPRESS SCRIPTS HOLDING COMPANY (NAS : ESRX) Files An 8-K Financial Statements a..
11/14 EXPRESS SCRIPTS HOLDING CO. : Other Events, Financial Statements and Exhibits (f..
11/14 NASDAQ 100 MOVERS : Jd, vod
11/09 EXPRESS SCRIPTS : Announces 2018 Financial Guidance Conference Call
11/09 EXPRESS SCRIPTS : Recognized as a Best Place to Work for LGBTQ Equality
11/08 EXPRESS SCRIPTS : HHS activates aid for uninsured U.S. Virgin Islands residents ..
11/07 Market Trends Toward New Normal in Public Service Enterprise Group, Rigel Pha..
11/06 JOSEPH SWEDISH : Anthem top executive Swedish to become adviser, Boudreaux named..
11/06 Anthem top executive Swedish to become adviser, Boudreaux named CEO
More news
News from SeekingAlpha
11/20 The Straw That Broke Mallinckrodt's Back?
11/18 RGA Q3 2017 Letter - Amazon's Share Of E-Commerce = PayPal's Opportunity
11/15 Express Scripts files for mixed shelf offering
11/14 Tracking Seth Klarman's Baupost Group Holdings - Q3 2017 Update
11/09 Express Scripts to host CC on December 14 on 2018 outlook
Financials ($)
Sales 2017 99 743 M
EBIT 2017 7 034 M
Net income 2017 3 118 M
Debt 2017 11 225 M
Yield 2017 -
P/E ratio 2017 11,54
P/E ratio 2018 10,57
EV / Sales 2017 0,46x
EV / Sales 2018 0,44x
Capitalization 35 081 M
Chart EXPRESS SCRIPTS HOLDING CO
Duration : Period :
Express Scripts Holding Co Technical Analysis Chart | ESRX | US30219G1085 | 4-Traders
Technical analysis trends EXPRESS SCRIPTS HOLDING CO
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Average target price 67,6 $
Spread / Average Target 9,2%
EPS Revisions
Managers
NameTitle
Timothy C. Wentworth President, Chief Executive Officer & Director
George Paz Chairman
Christine Houston Chief Operating Officer & Executive Vice President
James M. Havel Chief Financial Officer & Executive Vice President
Steven B. Miller Chief Medical Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
EXPRESS SCRIPTS HOLDING CO-9.96%35 081
WALGREENS BOOTS ALLIANCE-13.91%71 930
CVS HEALTH-10.43%71 598
MCKESSON CORPORATION1.20%29 630
CARDINAL HEALTH INC-20.09%18 128
AMERISOURCEBERGEN CORP.0.83%17 275